by CytexOrtho | Jun 15, 2023 | Newsletters
The June issue of the CytexOrtho newsletter covers our successful crowdfunding raise, our progress toward clinical trials, and our talk on capitol hill! If you would like to receive a copy of our future newsletters, be sure to sign up for our mailing lists via the...
by CytexOrtho | May 18, 2023 | In the News
On May 11th, 2023 Dr Brad Estes, CytexOrtho Co-founder and CEO, traveled to Washington D.C. to sit on a panel about the state of osteoarthritis (OA) in the United States, and the need for additional funding to move scientific advances combating OA to the clinic. The...
by CytexOrtho | May 1, 2023 | Disclosures
This is the 2023 Form C-AR as required by the SEC. 2023 Form C-AR View...
by CytexOrtho | Jan 17, 2023 | In the News
We are thrilled to announce that we just received a Breakthrough Device Designation from the United States Food and Drug Administration (FDA) for our novel hip cartilage repair technology. The intent of the Breakthrough Devices Program1 is to help patients have...
by CytexOrtho | Oct 20, 2022 | Newsletters
The October issue of the CytexOrtho newsletter covers our progression toward clinical trials, discussions with the FDA, and our new CRP award from NIH! If you would like to receive a copy of our future newsletters, be sure to sign up for our mailing lists via the...
